Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļGRFS
āļāļ·āđāļāļāļĢāļīāļĐāļąāļGrifols SA
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 17, 2006
āļāļĩāļāļĩāđāļAbia (Jose Ignacio)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ23833
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒDepository Receipt
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 17
āļāļĩāđāļāļĒāļđāđParque Empresarial Can Sant Joan
āđāļĄāļ·āļāļSANT CUGAT DEL VALLES
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻSpain
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ08174
āđāļāļĢāļĻāļąāļāļāđ34935710000
āđāļ§āđāļāđāļāļāđhttps://www.grifols.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļGRFS
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 17, 2006
āļāļĩāļāļĩāđāļAbia (Jose Ignacio)
Mr. Enrique De La Torre
Chief Compliance Officer
Mr. Roland Wandeler, Ph.D.
Mr. Roland Wandeler, Ph.D.
President - Biopharma
Ms. Irene Roche Font
Vice President - Accounting and Financial Services
Vice President - Accounting and Financial Services
Ms. Montseratt Ribas Loveras
Ms. Montseratt Ribas Loveras
Chief Communication and Reputation Officer
Chief Communication and Reputation Officer
Dr. Ester Masllorens Llinas
Dr. Ester Masllorens Llinas
Independent Director
Ms. Joanna Susan Le Couilliard
Ms. Joanna Susan Le Couilliard
Independent Director
Mr. Tomas Daga Gelabert
Other External Director
Mr. Raimon Grifols Roura
Vice Chairman of the Board, Proprietary Director
Vice Chairman of the Board, Proprietary Director
Ms. Nuria Martin Barnes
Non-Member Assistant Secretary of the Board of Directors
Non-Member Assistant Secretary of the Board of Directors
Mr. Ignacio Ramal Subira
Chief Internal Audit & Enterprise Risk Management
Chief Internal Audit & Enterprise Risk Management
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Enrique De La Torre
Chief Compliance Officer
Mr. Roland Wandeler, Ph.D.
Mr. Roland Wandeler, Ph.D.
President - Biopharma
Ms. Irene Roche Font
Vice President - Accounting and Financial Services
Vice President - Accounting and Financial Services
Ms. Montseratt Ribas Loveras
Ms. Montseratt Ribas Loveras
Chief Communication and Reputation Officer
Chief Communication and Reputation Officer
Dr. Ester Masllorens Llinas
Dr. Ester Masllorens Llinas
Independent Director
Ms. Joanna Susan Le Couilliard
Ms. Joanna Susan Le Couilliard
Independent Director